Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilazodone Efficacy and Safety in Major Depressive Disorder
NCT00285376Phase 3Completed
- Sponsor
- Genaissance Pharmaceuticals
- Start
- Feb 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vilazodone in major depressive disorder (MDD), sponsored by Genaissance Pharmaceuticals. Started Feb 2006; status: completed.
02
Drugs
vilazodone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00285376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00285376.